0001181431-15-008108.txt : 20150610
0001181431-15-008108.hdr.sgml : 20150610
20150610170415
ACCESSION NUMBER: 0001181431-15-008108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150609
FILED AS OF DATE: 20150610
DATE AS OF CHANGE: 20150610
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIND Therapeutics, Inc
CENTRAL INDEX KEY: 0001385228
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174913400
MAIL ADDRESS:
STREET 1: 325 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Biosciences, Inc
DATE OF NAME CHANGE: 20130130
FORMER COMPANY:
FORMER CONFORMED NAME: BIND Biosciences Inc
DATE OF NAME CHANGE: 20070105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYNCH DANIEL
CENTRAL INDEX KEY: 0001177082
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36072
FILM NUMBER: 15924029
4
1
rrd425604.xml
LYNCH F4
X0306
4
2015-06-09
0
0001385228
BIND Therapeutics, Inc
BIND
0001177082
LYNCH DANIEL
C/O BIND THERAPEUTICS, INC.
325 VASSAR STREET
CAMBRIDGE
MA
02139
1
0
0
0
Employee Stock Option (Right to Buy)
5.87
2015-06-09
4
A
0
20000
0
A
2025-06-08
Common Stock
20000
20000
D
Vests and becomes exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service as a member of the Board of Directors of the Issuer through the applicable vesting date.
/s/ Andrew Hirsch, Attorney-in-Fact for Daniel Lynch
2015-06-10